These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3119779)

  • 1. Characterization of astrocyte plasminogen activator.
    Toshniwal PK; Firestone SL; Barlow GH; Tiku ML
    J Neurol Sci; 1987 Sep; 80(2-3):277-87. PubMed ID: 3119779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor.
    Tranque P; Naftolin F; Robbins R
    Endocrinology; 1994 Jun; 134(6):2606-13. PubMed ID: 8194486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysis.
    Jeanneau C; Sultan Y
    Thromb Haemost; 1988 Jun; 59(3):529-34. PubMed ID: 3142087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
    Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
    Glia; 1992; 6(3):163-71. PubMed ID: 1335967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-type plasminogen activator in rat adrenal medulla.
    Kristensen P; Hougaard DM; Nielsen LS; Danø K
    Histochemistry; 1986; 85(5):431-6. PubMed ID: 3096916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).
    Hamaguchi M; Takahashi I; Takehara T; Takamatsu J; Saito H
    Biochim Biophys Acta; 1989 Nov; 1009(2):143-50. PubMed ID: 2508748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of plasminogen activator by cerebral astrocytes and its modulation.
    Toshniwal PK; Tiku ML; Tiku K; Skosey JL
    J Neurol Sci; 1987 Sep; 80(2-3):307-21. PubMed ID: 3681335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
    Masson C; Angles-Cano E
    Biochem J; 1988 Nov; 256(1):237-44. PubMed ID: 3146972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B
    Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of plasminogen activator from two human renal carcinoma cell lines.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].
    Orbe J; Montes R; Chordá C; Páramo JA; Rocha E
    Sangre (Barc); 1994 Aug; 39(4):261-6. PubMed ID: 7985055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies.
    Holvoet P; Lijnen HR; Collen D
    Eur J Biochem; 1986 Jul; 158(1):173-7. PubMed ID: 3089776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes mediate cerebral cortical neuronal axon and dendrite growth, in part, by release of fibroblast growth factor.
    Le R; Esquenazi S
    Neurol Res; 2002 Jan; 24(1):81-92. PubMed ID: 11783758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
    Gaussem P; Anglés-Cano E
    Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.